Table 3

Changes in health-related quality of life, dyspnoea, depression, anxiety and self-efficacy according to intervention group

OutcomeMean (SE) change from baselineMean (95% CI) difference in change from baselineMean (95% CI) adjusted difference in change from baseline*p Value
Action plan group (n=86)Control group (n=97)
SGRQ Total−0.4 (1.1)1.2 (1.3)−0.8 (−4.1 to 2.4)−1.3 (−4.4 to 1.9)0.42
SGRQ Activity2.6 (1.8)2.8 (1.7)−0.2 (−5.1 to 4.8)−0.4 (−5.1 to 4.2)0.85
SGRQ Symptom−3.6 (2.3)−0.6 (2.1)−3.1 (−9.1 to 3.0)−3.4 (−9.0 to 2.2)0.23
SGRQ Impact−0.1 (1.4)0.8 (1.0)−0.8 (−4.1 to 2.4)−1.3 (−4.4 to 1.9)0.42
HADS depression−0.2 (0.3)−0.3 (0.3)0.1 (−0.7 to 1.0)0.0 (−0.8 to 0.8)0.95
HADS anxiety−0.4 (0.3)−0.4 (0.3)0.0 (−0.9 to 0.9)0.0 (−0.9 to 0.8)0.97
Self-efficacy recognition−0.4 (0.1)0.3 (0.1)−0.8 (−1.1 to −0.4)−0.7 (−0.9 to −0.5)<0.001
Self-efficacy prevention / action−0.7 (0.1)0.2 (0.1)−1.0 (−1.3 to −0.7)−0.7 (−1.0 to −0.5)<0.001
  • * Difference in change from baseline adjusted for the baseline value of the parameter and centre; corresponding 95% CIs and p values are calculated using ANCOVA.

  • HADS, Hospital Anxiety and Depression Scale; SGRQ, St George's Respiratory Questionnaire.